Pages that link to "Q86613287"
Jump to navigation
Jump to search
The following pages link to Theodore A Gooley (Q86613287):
Displaying 26 items.
- Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome (Q33560410) (← links)
- Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. (Q33886907) (← links)
- High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes (Q34208626) (← links)
- High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis (Q34237823) (← links)
- Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas (Q34370320) (← links)
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood (Q34374133) (← links)
- A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease (Q34522152) (← links)
- A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation (Q35068749) (← links)
- Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model. (Q35220659) (← links)
- Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age (Q35608022) (← links)
- Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation (Q35848175) (← links)
- High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study (Q35925071) (← links)
- Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model (Q41843443) (← links)
- Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots (Q42743057) (← links)
- High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma (Q43966195) (← links)
- Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission (Q44287669) (← links)
- Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias (Q44329635) (← links)
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis. (Q44443172) (← links)
- Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning (Q44958576) (← links)
- Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older (Q46433183) (← links)
- CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies. (Q47329597) (← links)
- Increased AF1q gene expression in high-risk myelodysplastic syndrome. (Q53279719) (← links)
- Allogeneic hematopoietic stem cell transplantation for myelofibrosis (Q73812277) (← links)
- Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia (Q79817900) (← links)
- Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs (Q80489703) (← links)
- Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy (Q91385826) (← links)